Literature DB >> 26065322

An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.

L Alcazar-Fuoli1, Mj Buitrago, A Gomez-Lopez, E Mellado.   

Abstract

Aspergillus fumigatus is the most common mold involved in human infections. However, the number of non-fumigatus species able to cause disease is continuously increasing. Among them, Aspergillus lentulus is reported in hematological and cystic fibrosis patients and in those treated with corticosteroids. A. lentulus differs from A. fumigatus in some clinically relevant aspects such as virulence and antifungal susceptibility, showing high MICs to most antifungals. Previous studies proved that A. lentulus was pathogenic in immunocompromised mice, although the course of the infection was delayed compared to A. fumigatus. These differences could explain why A. lentulus is mostly found in mixed infections with A. fumigatus challenging the diagnosis and treatment. We used the alternative model host Galleria mellonella to compare virulence, host interaction, fungal burden and antifungal response when larvae were infected with A. fumigatus or A. lentulus alone, and with a mixture of both species. A. lentulus was pathogenic in G. mellonella but infected larvae did not respond to therapeutic doses of voriconazole. We were able to simultaneously detect A. fumigatus and A. lentulus by a multiplex Nested Real Time PCR (MN-PCR). Comparative analysis of larvae histological sections showed melanization of both species but presented a different pattern of immune response by haemocytes. Analysis of fungal burden and histology showed that A. lentulus survived in the G. mellonella despite the antifungal treatment in single and mixed infections. We conclude that the simultaneous presence of antifungal susceptible and resistant Aspergillus species would likely complicate the management of these infections.

Entities:  

Keywords:  Aspergillus spp; Galleria mellonella infection model; cyp51A; mixed infection; one-step single tube real time PCR

Mesh:

Substances:

Year:  2015        PMID: 26065322      PMCID: PMC4601236          DOI: 10.1080/21505594.2015.1025192

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  44 in total

1.  Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi.

Authors:  Conrad L Schoch; Keith A Seifert; Sabine Huhndorf; Vincent Robert; John L Spouge; C André Levesque; Wen Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-27       Impact factor: 11.205

2.  Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility.

Authors:  E Mellado; G Garcia-Effron; M J Buitrago; L Alcazar-Fuoli; M Cuenca-Estrella; J L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility.

Authors:  Emilia Mellado; Laura Alcazar-Fuoli; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

4.  A single-tube nested PCR for Pneumocystis carinii f. sp. hominis.

Authors:  X Tang; M S Bartlett; J W Smith; C H Lee
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease.

Authors:  Almudena Alhambra; Mercedes Catalán; María Dolores Moragues; Sonia Brena; José Pontón; Juan Carlos Montejo; Amalia del Palacio
Journal:  Rev Iberoam Micol       Date:  2008-12-31       Impact factor: 1.044

6.  Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.

Authors:  S Arunmozhi Balajee; Jennifer L Gribskov; Edward Hanley; David Nickle; Kieren A Marr
Journal:  Eukaryot Cell       Date:  2005-03

7.  Galleria mellonella as a model host to study Paracoccidioides lutzii and Histoplasma capsulatum.

Authors:  Luciana Thomaz; Rocío García-Rodas; Allan J Guimarães; Carlos P Taborda; Oscar Zaragoza; Joshua D Nosanchuk
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

8.  The ZrfC alkaline zinc transporter is required for Aspergillus fumigatus virulence and its growth in the presence of the Zn/Mn-chelating protein calprotectin.

Authors:  Jorge Amich; Rocío Vicentefranqueira; Emilia Mellado; Ana Ruiz-Carmuega; Fernando Leal; José Antonio Calera
Journal:  Cell Microbiol       Date:  2013-12-04       Impact factor: 3.715

9.  Galleria mellonella as a model host to study virulence of Candida.

Authors:  Ilse D Jacobsen
Journal:  Virulence       Date:  2014-01-02       Impact factor: 5.882

10.  Aspergillus species identification in the clinical setting.

Authors:  S A Balajee; J Houbraken; P E Verweij; S-B Hong; T Yaghuchi; J Varga; R A Samson
Journal:  Stud Mycol       Date:  2007       Impact factor: 16.097

View more
  14 in total

1.  Amino acid biosynthetic pathways as antifungal targets for fungal infections.

Authors:  Laura Alcazar-Fuoli
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

3.  Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.

Authors:  Michal Meir; Tatyana Grosfeld; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.

Authors:  Rocio Garcia-Rubio; Laura Alcazar-Fuoli; Maria Candida Monteiro; Sara Monzon; Isabel Cuesta; Teresa Pelaez; Emilia Mellado
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 5.  Aspergillus fumigatus-Related Species in Clinical Practice.

Authors:  Frédéric Lamoth
Journal:  Front Microbiol       Date:  2016-05-17       Impact factor: 5.640

Review 6.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

7.  A Novel Restraint Device for Injection of Galleria mellonella Larvae that Minimizes the Risk of Accidental Operator Needle Stick Injury.

Authors:  James P Dalton; Benedict Uy; Simon Swift; Siouxsie Wiles
Journal:  Front Cell Infect Microbiol       Date:  2017-03-28       Impact factor: 5.293

Review 8.  The Use of Galleria mellonella Larvae to Identify Novel Antimicrobial Agents against Fungal Species of Medical Interest.

Authors:  Kevin Kavanagh; Gerard Sheehan
Journal:  J Fungi (Basel)       Date:  2018-09-19

Review 9.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Authors:  Patrick Van Dijck; Jelmer Sjollema; Bruno P Cammue; Katrien Lagrou; Judith Berman; Christophe d'Enfert; David R Andes; Maiken C Arendrup; Axel A Brakhage; Richard Calderone; Emilia Cantón; Tom Coenye; Paul Cos; Leah E Cowen; Mira Edgerton; Ana Espinel-Ingroff; Scott G Filler; Mahmoud Ghannoum; Neil A R Gow; Hubertus Haas; Mary Ann Jabra-Rizk; Elizabeth M Johnson; Shawn R Lockhart; Jose L Lopez-Ribot; Johan Maertens; Carol A Munro; Jeniel E Nett; Clarissa J Nobile; Michael A Pfaller; Gordon Ramage; Dominique Sanglard; Maurizio Sanguinetti; Isabel Spriet; Paul E Verweij; Adilia Warris; Joost Wauters; Michael R Yeaman; Sebastian A J Zaat; Karin Thevissen
Journal:  Microb Cell       Date:  2018-06-14

Review 10.  Bioactive Peptides Against Fungal Biofilms.

Authors:  Karen G N Oshiro; Gisele Rodrigues; Bruna Estéfani D Monges; Marlon Henrique Cardoso; Octávio Luiz Franco
Journal:  Front Microbiol       Date:  2019-10-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.